Cargando…
Origins of Combination Therapy for Tuberculosis: Lessons for Future Antimicrobial Development and Application
Tuberculosis is a global health problem that causes the death of approximately 1.5 million people worldwide each year (WHO, p. 1–126, Global Tuberculosis Report, 2015). Treatment of drug-susceptible tuberculosis requires combination antimicrobial therapy with a minimum of four antimicrobial agents a...
Autores principales: | Kerantzas, Christopher A., Jacobs, William R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350467/ https://www.ncbi.nlm.nih.gov/pubmed/28292983 http://dx.doi.org/10.1128/mBio.01586-16 |
Ejemplares similares
-
The Future of Bacteriophage Therapy Will Promote Antimicrobial Susceptibility
por: Barber, Olivia Williams, et al.
Publicado: (2021) -
The Origin of Mucosal Immunity: Lessons from the Holobiont Hydra
por: Schröder, Katja, et al.
Publicado: (2016) -
Cancer chemoprevention: lessons learned and future directions
por: Brenner, D E, et al.
Publicado: (2005) -
Nanopore Sequencing for Mycobacterium tuberculosis: a Critical Review of the Literature, New Developments, and Future Opportunities
por: Dippenaar, Anzaan, et al.
Publicado: (2022) -
Fame and future of faecal transplantations — developing next-generation therapies with synthetic microbiomes
por: Vos, Willem M
Publicado: (2013)